RecruitingNot ApplicableNCT06638996

Acute Psychological and Physiological Effects of Cannabigerol

Psychological and Physiological Effects of Cannabigerol (CBG)


Sponsor

Washington State University

Enrollment

100 participants

Start Date

Oct 28, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the acute effects of cannabigerol (CBG) on various psychological (e.g., anxiety, stress, mood, memory, impairment, intoxication, side effects) and physiological (blood pressure, cortisol, heart rate variability, electrodermal activity, pain tolerance, temperature) outcomes. Further, potential side effects of CBG (sleepiness/fatigue, dry mouth/eyes, increased appetite, and dizziness nausea) will be assessed. As such, the study is focused on better understanding some of the potentially beneficial and detrimental effects of CBG on humans.


Eligibility

Min Age: 21 Years

Inclusion Criteria1

  • + years of age Fluent in English

Exclusion Criteria1

  • Illiterate Serious psychiatric disorders (i.e., psychotic disorders, bipolar disorders) Intellectual disability Chronic neurological disorders (e.g., head injuries, brain tumors, Parkinson's disease) Diabetes Low blood pressure Pregnant or breastfeeding Recent illicit drug use (past 2 months) - does not include cannabis Dietary restrictions preventing them from eating muffin, yogurt, milk/juice

Interventions

DIETARY_SUPPLEMENTCBG Intervention

50 mg CBG Administered

OTHERPlacebo Intervention

Participants will be administered a placebo


Locations(1)

Washington State University - Pullman Campus

Pullman, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06638996